Delivery Order SPE2DB22D2005-SPE2DB24FJJH6
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,629.58 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which was not set aside for any specific business type. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a potential value of $24,443.70 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order contract is issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has a potential value of $6,518.32 and a completion date of January 26, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The $6,518.32 contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is issued under a larger indefinite delivery contract (IDC) held by...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $21,184.54 contract is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside contract....
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The $1,552.08 contract has a completion date of February 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 100 MG/ML SYRINGE medication. The $8,147.90 contract has a performance period through January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order awarded by DLA Troop Support Medical to supply pharmaceuticals...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML syringes. The contract has a potential value of $3,259.16 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization based in Conshohocken, Pennsylvania, and is the parent company of Cencora, Inc....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 100 MG/ML SYRINGE/ML pharmaceutical products. The contract has a potential value of $8,147.90 and a completion date of January 29, 2024. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this delivery...
- The Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The $3,080.04 firm fixed-price contract has an ultimate completion date of August 26, 2024 and was not set aside for any specific business category. AmerisourceBergen, through its Corporate Office division, will deliver the medical supplies to support various federal healthcare programs and facilities,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJJH6Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 100 MG/ML SYRINGEML pharmaceutical products. The $15,520.80 contract has a completion date of March 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and has received numerous prior federal contract awards from DLA to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities. This delivery order is issued under a $999,999,999.00 indefinite delivery contract awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide a comprehensive range of medications and healthcare materials to DLA Troop Support Medical facilities worldwide. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 2/29/24 |